DANBURY, Conn., & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will host an Analyst and
Investor Conference in New York City on Tuesday, June 18, 2019.
Management will provide an update on the business, with presentations
starting at 9:00 a.m. ET and concluding at approximately 1:00 p.m. ET.
Registration is required to attend the event.
All are invited to listen to the live event and view the presentation
slides via webcast on the IQVIA Investor Relations website at http://ir.iqvia.com.
The discussion will also be available by dialing +1-800-786-0540 in the
U.S. and Canada, or +1-212-231-2936 for international callers.
A replay of the webcast will be available later that day, following the
conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com.
IQVIA is a leading global provider of advanced analytics, technology
solutions and contract research services to the life sciences industry.
Formed through the merger of IMS Health and Quintiles, IQVIA applies
human data science — leveraging the analytic rigor and clarity of data
science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
information on a scale that helps healthcare stakeholders identify
disease patterns and correlate with the precise treatment path and
therapy needed for better outcomes. IQVIA’s insights and execution
capabilities help biotech, medical device and pharmaceutical companies,
medical researchers, government agencies, payers and other healthcare
stakeholders tap into a deeper understanding of diseases, human
behaviors and scientific advances, in an effort to advance their path
toward cures. To learn more, visit www.iqvia.com.
Andrew Markwick, IQVIA Investor Relations ([email protected])
Tor Constantino, IQVIA Media Relations ([email protected])